Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3683130010 | Furosemide 20 mg and spironolactone 50 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3683131014 | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46604001000001116 | Spironolactone 50mg / Furosemide 20mg capsules | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Spironolactone+loop diuretic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Diuretic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Product containing furosemide and spironolactone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Furosemide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Spironolactone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Product containing furosemide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Product containing spironolactone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Spironolactone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has basis of strength substance | Spironolactone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Furosemide | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has basis of strength substance | Furosemide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has basis of strength substance | Furosemide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has basis of strength substance | Spironolactone | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has precise active ingredient | Furosemide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has precise active ingredient | Spironolactone | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Product containing only furosemide and spironolactone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Plays role | Loop diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has precise active ingredient | Spironolactone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has precise active ingredient | Furosemide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Furosemide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has active ingredient | Spironolactone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | capsule.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Spironolactone + Furosemide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | VMP non-availability indicator | Re-introduced | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has specific active ingredient | Furosemide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has specific active ingredient | Spironolactone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has dispensed dose form | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Spironolactone+frusemide 50mg/20mg capsule - product | Is a | False | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Lasilactone capsules (Borg Medicare Ltd) | Is a | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Spironolactone 50mg / Furosemide 20mg capsules 28 capsule | Is pack of | False | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Lasilactone capsules (Waymade Ltd) | Is a | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Is pack of | False | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Lasilactone capsules (Dowelhurst Ltd) | Is a | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Lasilactone capsules (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Spironolactone 50mg / Furosemide 20mg capsules 50 capsule | Is pack of | False | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Spironolactone 50mg / Furosemide 20mg capsules 28 capsule | Has VMP | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Spironolactone 50mg / Furosemide 20mg capsules 50 capsule | Has VMP | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Has VMP | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Lasilactone capsules (Lexon (UK) Ltd) | Is a | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
| Lasilactone capsules (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR